Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 78 articles:
HTML format

Single Articles

    January 2021
  1. GANT VU, Junco JJ, Terrell M, Rashid R, et al
    Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
    PLoS One. 2021;16:e0244863.
    PubMed     Abstract available

  2. MASHIMA K, Oh I, Fujiwara K, Izawa J, et al
    Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.
    PLoS One. 2021;16:e0245232.
    PubMed     Abstract available

  3. JU HY, Lee JW, Cho HW, Hyun JK, et al
    DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.
    PLoS One. 2021;16:e0245667.
    PubMed     Abstract available

  4. SEITA A, Nakaoka H, Okura R, Wakamoto Y, et al
    Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.
    PLoS One. 2021;16:e0236534.
    PubMed     Abstract available

    The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    PLoS One. 2021;16:e0247491.
    PubMed     Abstract available

  6. MOSQUERA ORGUEIRA A, Peleteiro Raindo A, Cid Lopez M, Antelo Rodriguez B, et al
    Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
    PLoS One. 2021;16:e0247093.
    PubMed     Abstract available

  7. GHOBADI MZ, Emamzadeh R, Mozhgani SH
    Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia/lymphoma; the battle between oncogenes and anti-oncogenes.
    PLoS One. 2021;16:e0247713.
    PubMed     Abstract available

  8. UMAMAHESWARAN G, Kadambari D, Muthuvel SK, Kumar NAN, et al
    Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer.
    PLoS One. 2021;16:e0247989.
    PubMed     Abstract available

  9. CHANG Y, Guyatt GH, Teich T, Dawdy JL, et al
    Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
    PLoS One. 2021;16:e0249087.
    PubMed     Abstract available

  10. ELENS I, Deprez S, Billiet T, Sleurs C, et al
    Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
    PLoS One. 2021;16:e0250228.
    PubMed     Abstract available

  11. YOO KH, Kim HJ, Min YH, Hong DS, et al
    Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
    PLoS One. 2021;16:e0251011.
    PubMed     Abstract available

  12. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed     Abstract available

  13. MOHSENI M, Kucharski C, K C RB, Nasrullah M, et al
    Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    PLoS One. 2021;16:e0251719.
    PubMed     Abstract available

  14. KOVY P, Orfi Z, Bors A, Kozma A, et al
    Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    PLoS One. 2021;16:e0253386.
    PubMed     Abstract available

  15. KIM SK, Goughnour PC, Lee EJ, Kim MH, et al
    Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    PLoS One. 2021;16:e0246106.
    PubMed     Abstract available

  16. PONVILAWAN B, Kungwankiattichai S, Charoenngam N, Owattanapanich W, et al
    Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253896.
    PubMed     Abstract available

  17. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed     Abstract available

  18. KARAMI K, Akbari M, Moradi MT, Soleymani B, et al
    Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
    PLoS One. 2021;16:e0254976.
    PubMed     Abstract available

  19. MOUSTAFA R, Albouni T, Aziz G
    The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    PLoS One. 2021;16:e0253842.
    PubMed     Abstract available

  20. FAUZI YR, Nakahata S, Chilmi S, Ichikawa T, et al
    Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    PLoS One. 2021;16:e0256320.
    PubMed     Abstract available

  21. ZHANG W, Jang E
    Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
    PLoS One. 2021;16:e0256801.
    PubMed     Abstract available

  22. LONCAREVIC IF, Toepfer S, Hubold S, Klingner S, et al
    Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads.
    PLoS One. 2021;16:e0242529.
    PubMed     Abstract available

  23. VON BEEK C, Alriksson L, Palle J, Gustafson AM, et al
    Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
    PLoS One. 2021;16:e0256708.
    PubMed     Abstract available

  24. GONZALEZ-RINCON J, Garcia-Vela JA, Gomez S, Fernandez-Cuevas B, et al
    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
    PLoS One. 2021;16:e0257353.
    PubMed     Abstract available

  25. OCHIAI C, Miyauchi S, Kudo Y, Naruke Y, et al
    Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing.
    PLoS One. 2021;16:e0256588.
    PubMed     Abstract available

  26. ROSENTHAL SH, Gerasimova A, Ma C, Li HR, et al
    Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    PLoS One. 2021;16:e0243683.
    PubMed     Abstract available

  27. MATSUO S, Nishinaka-Arai Y, Kazuki Y, Oshimura M, et al
    Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    PLoS One. 2021;16:e0247595.
    PubMed     Abstract available

  28. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available

  29. LUONG A, Cerignoli F, Abassi Y, Heisterkamp N, et al
    Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    PLoS One. 2021;16:e0258140.
    PubMed     Abstract available

  30. BAO F, Zhang L, Pei X, Lian C, et al
    MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    PLoS One. 2021;16:e0256995.
    PubMed     Abstract available

  31. MOSQUERA ORGUEIRA A, Ferreiro Ferro R, Diaz Arias JA, Aliste Santos C, et al
    Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    PLoS One. 2021;16:e0248886.
    PubMed     Abstract available

  32. PARKER C, Zomer E, Liew D, Ayton D, et al
    Characterising experiences with acute myeloid leukaemia using an Instagram content analysis.
    PLoS One. 2021;16:e0250641.
    PubMed     Abstract available

  33. ONO R, Masuya M, Inoue N, Shinmei M, et al
    Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    PLoS One. 2021;16:e0248425.
    PubMed     Abstract available

  34. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available

  35. MAHESHWARI VK, Slader C, Dani N, Gkitzia C, et al
    Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
    PLoS One. 2021;16:e0259076.
    PubMed     Abstract available

  36. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed     Abstract available

  37. SADATO D, Hirama C, Kaiho-Soma A, Yamaguchi A, et al
    Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
    PLoS One. 2021;16:e0255257.
    PubMed     Abstract available

  38. NAGY-BALO Z, Kiss R, Demeter J, Bodor C, et al
    BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.
    PLoS One. 2021;16:e0254853.
    PubMed     Abstract available

  39. HOFFMANN H, Baldow C, Zerjatke T, Gottschalk A, et al
    How to predict relapse in leukemia using time series data: A comparative in silico study.
    PLoS One. 2021;16:e0256585.
    PubMed     Abstract available

  40. CARDOSO BORGES F, Ramos A, Lourenco A, Gomes da Silva M, et al
    Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
    PLoS One. 2021;16:e0258423.
    PubMed     Abstract available

    January 2020
  41. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available

  42. AGUILERA-DIAZ A, Vazquez I, Ariceta B, Manu A, et al
    Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
    PLoS One. 2020;15:e0227986.
    PubMed     Abstract available

  43. SOK P, Lupo PJ, Richard MA, Rabin KR, et al
    Utilization of archived neonatal dried blood spots for genome-wide genotyping.
    PLoS One. 2020;15:e0229352.
    PubMed     Abstract available

  44. WANG M, Zhang C
    Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    PLoS One. 2020;15:e0232520.
    PubMed     Abstract available

  45. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231588.
    PubMed     Abstract available

  46. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available

  47. KOZLOVA V, Ledererova A, Ladungova A, Peschelova H, et al
    CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
    PLoS One. 2020;15:e0229170.
    PubMed     Abstract available

  48. ROBERTO G, Spini A, Bartolini C, Moscatelli V, et al
    Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.
    PLoS One. 2020;15:e0229973.
    PubMed     Abstract available

  49. CUESTA LM, Liron JP, Nieto Farias MV, Dolcini GL, et al
    Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0234939.
    PubMed     Abstract available

  50. MAALAND AF, Saidi A, Torgue J, Heyerdahl H, et al
    Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003.
    PLoS One. 2020;15:e0230526.
    PubMed     Abstract available

  51. SCHONHERZ AA, Bodker JS, Schmitz A, Brondum RF, et al
    Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact.
    PLoS One. 2020;15:e0229593.
    PubMed     Abstract available

  52. RODRIGUES JCG, Souza TP, Pastana LF, Ribeiro Dos Santos AM, et al
    Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.
    PLoS One. 2020;15:e0231651.
    PubMed     Abstract available

  53. Correction: Effect of bovine leukemia virus (BLV) infection on bovine mammary epithelial cells RNA-seq transcriptome profile.
    PLoS One. 2020;15:e0236912.
    PubMed     Abstract available

  54. LI J, Ran Q, Xu B, Luo X, et al
    Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis.
    PLoS One. 2020;15:e0236124.
    PubMed     Abstract available

  55. LAVAU CP, Aumann WK, Sze SK, Gupta V, et al
    The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
    PLoS One. 2020;15:e0232036.
    PubMed     Abstract available

  56. PRIEST ND, Dauer LT, Hoel DG
    Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.
    PLoS One. 2020;15:e0232597.
    PubMed     Abstract available

  57. YOO KH, Cho J, Han B, Kim SH, et al
    Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults.
    PLoS One. 2020;15:e0235503.
    PubMed     Abstract available

  58. Retraction: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells.
    PLoS One. 2020;15:e0237489.

  59. DRIEHUIS E, Oosterom N, Heil SG, Muller IB, et al
    Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0237488.
    PubMed     Abstract available

  60. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    PubMed     Abstract available

  61. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available

  62. GRAYSON JM, Perez MD, Blevins R, Coe BN, et al
    Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity.
    PLoS One. 2020;15:e0234778.
    PubMed     Abstract available

  63. JOHANSSON KA, Okland JM, Skaftun EK, Bukhman G, et al
    Estimating Health Adjusted Age at Death (HAAD).
    PLoS One. 2020;15:e0235955.
    PubMed     Abstract available

  64. BORIES P, Prade N, Lagarde S, Cabarrou B, et al
    Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
    PLoS One. 2020;15:e0238795.
    PubMed     Abstract available

  65. DELARMELINA E, Buzelin MA, Souza BS, Souto FM, et al
    High positivity values for bovine leukemia virus in human breast cancer cases from Minas Gerais, Brazil.
    PLoS One. 2020;15:e0239745.
    PubMed     Abstract available

  66. LEWIS TR, Smith J, Griffin K, Aguiar S, et al
    NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.
    PLoS One. 2020;15:e0236839.
    PubMed     Abstract available

  67. NAGEL S, Pommerenke C, Meyer C, MacLeod RAF, et al
    Aberrant expression of NKL homeobox genes HMX2 and HMX3 interferes with cell differentiation in acute myeloid leukemia.
    PLoS One. 2020;15:e0240120.
    PubMed     Abstract available

  68. RATTANATHAMMETHEE T, Tuitemwong P, Thiennimitr P, Sarichai P, et al
    Gut microbiota profiles of treatment-naive adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
    PLoS One. 2020;15:e0236460.
    PubMed     Abstract available

  69. LUO L, Kang H, Li X, Ness SA, et al
    Two-step mixed model approach to analyzing differential alternative RNA splicing.
    PLoS One. 2020;15:e0232646.
    PubMed     Abstract available

  70. TURK S, Turk C, Akbar MW, Kucukkaraduman B, et al
    Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.
    PLoS One. 2020;15:e0242497.
    PubMed     Abstract available

  71. SZAKACS Z, Hegyi PJ, Farkas N, Hegyi P, et al
    Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.
    PLoS One. 2020;15:e0243045.
    PubMed     Abstract available

  72. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    PubMed     Abstract available

  73. ZHANG W, Kuang P, Liu T
    Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis.
    PLoS One. 2020;15:e0243657.
    PubMed     Abstract available

  74. BURNS JE, Reyes Perez D, Li Y, Gomez Garcia W, et al
    Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican Republic.
    PLoS One. 2020;15:e0243795.
    PubMed     Abstract available

  75. SAHAJPAL NS, Mondal AK, Ananth S, Njau A, et al
    Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
    PLoS One. 2020;15:e0240976.
    PubMed     Abstract available

  76. YUAN B, El Dana F, Ly S, Yan Y, et al
    Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-beta-p38-ALDH2 pathway.
    PLoS One. 2020;15:e0242809.
    PubMed     Abstract available

    January 2019
  77. NAGEL S, Scherr M, MacLeod RAF, Pommerenke C, et al
    NKL homeobox gene activities in normal and malignant myeloid cells.
    PLoS One. 2019;14:e0226212.
    PubMed     Abstract available

  78. ALI EA, Kalli M, Wan D, Nakamura R, et al
    Characterization of human FcepsilonRIalpha chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines.
    PLoS One. 2019;14:e0221034.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.